MD, PhD, Section of Diabetes, Endocrinology, and Nutrition. Hospital "Dr Josep Trueta" of Girona, Carretera de França s/n, 17007 Girona, Spain.
J Clin Endocrinol Metab. 2013 Oct;98(10):E1655-60. doi: 10.1210/jc.2013-1496. Epub 2013 Aug 8.
Circulating microRNAs (miRNAs) are valuable biomarkers of metabolic diseases and potential therapeutic targets in this field.
Our objective was to define the circulating pattern of miRNAs in childhood obesity. DESIGN, SETTINGS, AND MAIN OUTCOME MEASURE: The genome-wide circulating miRNA profile was assessed by RT-PCR in 10 boys (5 lean and 5 obese children). The most relevant miRNAs were cross-sectionally validated in 85 lean versus 40 obese children (63 boys and 62 girls) and longitudinally evaluated in samples from the same children when they were ≈ 7 and ≈ 10 years old (23 boys and 22 girls).
The cross-sectional validation study disclosed that 15 specific circulating miRNAs were significantly deregulated in prepubertal obesity, including the decreased miR-221 and miR-28-3p and increased concentrations in plasma of miR-486-5p, miR-486-3p, miR-142-3p, miR-130b, and miR-423-5p (all P < .0001). The circulating concentration of these miRNAs was significantly associated with body mass index and other measures of obesity such as percent fat mass, waist, regional fat distribution and with laboratory parameters such as homeostasis model assessment of insulin resistance, high-molecular-weight adiponectin, C-reactive protein, and circulating lipids in concordance with anthropometric associations. Plasma concentrations of 10 of these circulating miRNAs changed significantly and differently during the 3-year follow-up in children who increased or decreased their normalized weight.
This study provides the first evidence that circulating miRNAs are deregulated in prepubertal obese children. Thus, the very early detection of an abnormal circulating miRNA profile may be a promising strategy to identify obese children who may suffer from metabolic abnormalities.
循环 microRNAs(miRNAs)是代谢性疾病有价值的生物标志物,也是该领域的潜在治疗靶点。
本研究旨在确定儿童肥胖症的循环 miRNA 模式。
设计、设置和主要观察结果:通过 RT-PCR 评估了 10 名男孩(5 名瘦和 5 名肥胖儿童)的全基因组循环 miRNA 谱。在 85 名瘦对照者与 40 名肥胖者(63 名男孩和 62 名女孩)中进行了横断面验证,并在同一儿童大约 7 岁和 10 岁时对来自相同儿童的样本进行了纵向评估(23 名男孩和 22 名女孩)。
横断面验证研究显示,15 种特定的循环 miRNA 在青春期前肥胖症中显著失调,包括 miR-221 和 miR-28-3p 的降低,以及 miR-486-5p、miR-486-3p、miR-142-3p、miR-130b 和 miR-423-5p 的血浆浓度增加(所有 P<0.0001)。这些 miRNA 的循环浓度与体重指数和其他肥胖指标(如脂肪百分比、腰围、局部脂肪分布)以及与肥胖相关的实验室参数(如胰岛素抵抗的稳态模型评估、高分子量脂联素、C 反应蛋白和循环脂质)显著相关。在体重正常化增加或减少的儿童中,这些循环 miRNA 中的 10 种在 3 年随访期间的变化显著且不同。
本研究首次提供了证据表明,循环 miRNA 在青春期前肥胖儿童中失调。因此,异常循环 miRNA 谱的早期检测可能是识别可能患有代谢异常的肥胖儿童的有前途的策略。